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Abstract
Background: The Center for Disease Control and Prevention (CDC) indicates that one of the largest problems
threatening healthcare includes antibiotic resistance. Tetracycline, an effective antibiotic that has been in use for
many years, is becoming less successful in treating certain pathogens. To better understand the temporal patterns
in the growth of antibiotic resistance, patient diagnostic test records can be analyzed.
Methods: Data mining methods including frequent item set mining and association rules via the Apriori algorithm
were used to analyze results from 80,241 Target Enriched Multiplex-PCR (TEM-PCR) reference laboratory tests. From
the data mining results, five common respiratory pathogens and their co-detection rates with tetracycline resistance
genes (TRG) were further analyzed and organized according to year, patient age, and geography.
Results: From 2010, all five pathogens were associated with at least a 24% rise in co-detection rate for TRGs. Patients
from 0–2 years old exhibited the lowest rate of TRG co-detection, while patients between 13–50 years old displayed
the highest frequency of TRG co-detection. The Northeastern region of the United States recorded the highest rate of
patients co-detected with a TRG and a respiratory pathogen. Along the East–west gradient, the relative frequency of
co-detection between TRGs and respiratory pathogens decreased dramatically.
Conclusions: Significant trends were uncovered regarding the co-detection frequencies of TRGs and respiratory
pathogens over time. It is valuable for the field of public health to monitor trends regarding the spread of resistant
infectious disease, especially since tetracycline continues to be utilized a treatment for various microbial infections.
Analyzing large datasets containing TEM-PCR results for co-detections provides valuable insights into trends of antibiotic
resistance gene expression so that the effectiveness of first-line treatments can be continuously monitored.
Background
In 1948, tetracycline was one of the first antibiotics dis-
covered that disrupted ribosomal subunit assembly in
bacterial pathogens. Tetracycline was advantageous over
existing agents because the medication was inexpensive
and had broad-spectrum response, but with a lower level
of allergenic properties [1]. As a result, physicians began
to prescribe the antibiotic to patients for many bacterial
infections [2]. Over time, tetracycline appeared in agri-
culture, as farmers learned to fortify animal feeds with
the antibiotic as it promoted growth and decreased the
spread of bacterial pathogens [3-6]. Tetracycline was
also sprayed on crops to halt the transmission of plant
diseases [7]. By 1990, the rampant utilization of tetracyc-
line had resulted in an increase in the number of tetra-
cycline resistant infections.
The United States Centers for Disease Control and
Prevention (CDC) has identified antibiotic resistance as
one of the largest problems threatening global health.
Antibiotic resistance directly costs healthcare over $20
billion annually; after including lost productivity, the
total costs exceed $35 billion [8]. These enormous costs
of tetracycline resistance may be largely unnecessary, as
over 50% of the antibiotics prescribed are unnecessary
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[8]. The CDC, The United States Food and Drug Ad-
ministration (FDA), and The United States Department
of Agriculture are trying to modify policies regarding the
prescription of medical antibiotics and their usage in
agriculture to attempt to halt the growth of antibiotic re-
sistance [9]. However, agriculturalists are reluctant to
follow these policy changes because of a lack of factual
evidence linking excess usage to rising levels of resist-
ance. Even if this aspect of tetracycline resistance is
widely disputed, the CDC strongly argues that tracking
trends in existing antibiotic infections is a key weapon in
preventing new antibiotic resistant infections.
Target Enriched Multiplex-Polymerase Chain Reaction
(TEM-PCR™) (Diatherix Laboratories Inc. Huntsville, AL)
has the ability to simultaneously detect Methicillin Sus-
ceptible Staphylococcus aureus (S.aureus), Methicillin
Resistant Staphylococcus aureus (MRSA), Streptococcus
pneumoniae (S. pneumoniae), Haemophilus influenzae
(H. influenzae), Moraxella catarrhalis (M. catarrhalis),
and tetracycline resistance genes (TRG) tet (K) and tet
(M) [10-14]. TEM-PCR is a nucleic acid multiplex tech-
nology that includes two main amplification steps: target
enrichment and subsequent exponential amplification
[10-14]. For the target enrichment step, two pairs of
nested gene-specific primers (Fo, forward out; Fi, forward
in; Ri reverse in, Ro reverse out) are designed for each tar-
get. Low concentrations of the nested primers are used to
amplify the target DNA, which will be exponentially amp-
lified in the next step. The Fi and Ri primers contain a
unique tag sequence that can be recognized by a universal
set of forward and biotin-labeled reverse SuperPrimers. In
the exponential amplification step, the SuperPrimers are
present at a concentration that allows for asymmetric
PCR amplification of the biotin-labeled single-stranded
DNA targeted by the reverse SuperPrimer. Target-specific
detection probes are then coupled to carboxyl groups on a
bead-based substrate, and probe fluorescence is read using
a bead-based detection platform.
Previous literature has documented the rise in tetra-
cycline resistant pathogens and warned of the possible
medical consequences regarding antimicrobial immunity
[1,2,15-17]. This descriptive study analyzed a dataset of
80,421 patient TEM-PCR test results, and explored the
co-detections between tetracycline resistance genes and
the respiratory pathogens. By elucidating these co-
detection patterns, the study contributes to the know-
ledge surrounding tetracycline resistance and aids in
accomplishing the ultimate goals of optimizing patient
care and reducing unnecessary healthcare costs.
Methods
TEM-PCR
Nucleic acid extraction for TEM-PCR was performed
using a KingFisher™ system (Thermo Scientific). The
amplification steps were completed using a GeneAmp®
PCR System 9700 thermocycler (Applied Biosystems).
Probe fluorescence was read using a Luminex detection
platform. TEM-PCR is a proprietary testing assay with
detailed procedures and SOPs under the ownership of
Diatherix Laboratories Inc.
Data mining methods
The two techniques used to elucidate relationships in
these data are frequent item sets and association rules via
the Apriori algorithm [18-22]. Briefly, the Apriori algo-
rithm is a widely used algorithm that is commonly
applied to transactional datasets. Frequent item sets are
groups of DNA markers that occur more frequently than
a minimum support level in the database. For example,
in this dataset, TRG and S. pneumoniae were co-
detected in 19.8% of the tests that identified at least one
marker, which is above the minimum support count of
50 positive tests. The Apriori algorithm assembles fre-
quent item sets into association rules that indicate con-
ditional frequency. For example, the rule {A, B} = > {C}
indicates that when A and B are found, C is also fre-
quently found. The confidence of an association rule
indicates its conditional probability in the dataset, that is
P(C | A,B). A rule’s interestingness measure lift indicates
the degree of independence between the antecedent and
the consequent, with values greater than 1 indicating an
interesting rule.
Full details of support count, support, confidence, and
lift can be found in publications [23,24]. Data mining
methods described here were recently used in many
biomedical publications [19,23-26]. One publication that
clearly explains the methods applied in this study in-
cludes a paper by Naulaerts et al. [27]. The confidence,
support, lift, and support count values from the Apriori
algorithm promoted further co-detections analysis of the
5 selected respiratory pathogens and TRGs.
Retrospective co-detection analysis of reference
laboratory data
Using reference laboratory TEM-PCR data, 80,241 patient
tests results were analyzed for the detection of S. aureus,
MRSA, S. pneumoniae, H. influenzae, M. catarrhalis, and
TRGs. 49,840 (62.1%) tests were detected for one patho-
gen or TRG. The co-detection rates between each patho-
gen and TRG were further analyzed by year, patient age by
year, and geography. In all categorical subsets, results were
analyzed for all respiratory samples from November 9,
2009-August 7, 2013. The analysis of M. catarrhalis began
on September 30, 2011 after genetic targets for this patho-
gen were added to the multiplexing assay. Data reflecting
multiple samples assayed from a given patient on a single
date were removed from the analysis. The sample size for
each year was within the range of 6,396 (2009) < X <
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26,841 (2012). Patient age was organized into 4 groups
(0 (exclusive)-2 (inclusive)], (2–13], (13–50], and (50–100].
91.1% of patients aged (0–2], 94.7% of patients aged
(2–13], 92.4% patients aged (13–50], and 76.6% of pa-
tients aged (50–100] had specimen collected by nasal,
nasalpharangeal, or throat swab. 8.7% of patients age
(50–100] had sputum samples collected. Other speci-
men sources which represented a very small percentage
of patients included aspirate, mucus, or bronchial or
nasal washes. Results were included from each state
where samples were collected within the sample size
range of 60 (Maryland) < X < 16,985 (Tennessee). Pa-
tient sample size for each categorical subset including
year, age group, and geographical state can be seen in
Additional file 1: Tables S1-S7. Data analyzed comes
from the frequency of patients that tested positive for
the simultaneous presence of one pathogen and a TRG.
Further molecular testing or bacterial plating by culture
was not done to verify if these pathogens were the
source of detected TRGs and further traditional testing
was out of the scope of this study. Inclusion criteria
were defined as submission for respiratory pathogen
testing, without regard to age, demographic categories,
or other medical conditions.
All of the database information was archived and orga-
nized using Microsoft SQL Server Management Studio
2012. Graphical analysis and statistics including scatter
plots with loess smoothing, confidence intervals, vari-
ance, and heat maps were performed in the R language,
with ggplot2 [28,29]. Confidence intervals were at 95%
confidence and constructed via the Jefferys prior [30].
Tables were generated in Microsoft Excel 2012. All
reference laboratory tests were conducted at Diatherix
Laboratories Inc. in Huntsville, AL.
Results
The Apriori algorithm created a list of the 25 most fre-
quent item sets found throughout the respiratory results
database (Table 1). The largest measurements of support
included TRGs (40.5%), S. pneumoniae (36.3%), H. influ-
enzae (28.7%), and M. catarrhalis (25.1%). S. pneumo-
niae and H. influenzae were co-detected with TRGs
19.8% and 15.1% of all positive tests results. MRSA and
S. aureus were detected 12.4% and 10.0% of all positive
results, respectively. 6.5% of all positive tests included
co-detection for MRSA and TRGs and 4.1% included
simultaneous detection between S. aureus and TRGs.
From the frequent item set results, the Apriori algorithm
identified the 25 association rules with the highest levels of
support (Table 2). The top of the table includes the rules
{S. pneumoniae} = > {Tetracycline}, {H. influenzae} = >
{Tetracycline}, and {H. influenzae, M. catarrhalis} = >
{S. pneumoniae} with 19.8%, 15.1%, and 7.2% support,
respectively. Each of the highlighted association rules
indicates a pathogen of interest or TRG that all have
confidence measurements over 50.9% and lift values
over 1.3. This confidence threshold establishes that,
given the antecedent of a rule, the consequent is found
in at least 50.9% of the cases. Since each rule had a lift
measurement over 1, they were all considered to be
rules of interest. From these results, and from literature
associating TRGs with specific gram-positive bacteria,
we sought to elucidate temporal co-detection patterns
to better understand how patient age and geography re-
late to TRG co-detection.
Figure 1 displays a scatterplot including the frequen-
cies of respiratory pathogens co-detected with TRGs by
year. It is clear that the frequency of co-detection be-
tween each pathogen and TRG increased with time.
From January 2010- August 2013, the percentage of gram-
positive bacteria S. aureus, MRSA, and S. pneumoniae co-
detected with TRGs rose 43%, 26%, and 27%, respectively.
From January 2010- August 2013, the frequency of gram-
negative bacteria H. influenzae and M. catarrhalis co-





{S. pneumoniae} 18,113 36.34%
{H. influenzae} 14,281 28.65%
{M. catarrhalis} 12,491 25.06%
{S. pneumoniae, Tetracycline} 9,850 19.76%
{H. influenzae, Tetracycline} 7,543 15.13%
{H. influenzae, S. pneumoniae} 6,231 12.50%
{MRSA} 6,175 12.39%
{S. pneumoniae, M. catarrhalis} 5,864 11.77%
{Tetracycline, M. catarrhalis} 5,864 11.04%
{CoxEchovirus1} 5,027 10.09%
{S. aureus} 4,980 9.99%
{Rhinovirus} 4,151 8.33%
{H. influenzae, M. catarrhalis} 4,089 8.20%
{H. influenzae, S. pneumoniae, Tetracycline} 3,603 7.23%
{MRSA, Tetracycline} 3,066 6.15%
{Parainfluenza} 3,027 6.07%
{S. pneumoniae, Tetracycline, M. catarrhalis} 2,987 5.99%
{H. influenzae, S. pneumoniae, M. catarrhalis} 2,486 4.99%
{K.pneumoniae} 2,160 4.33%
{S. aureus, Tetracycline} 2,025 4.06%
{H. influenzae, Tetracycline, M. catarrhalis} 1,966 3.94%
{Human Metapneumovirus} 1,955 3.92%
{A.baumannii} 1,801 3.61%
The first 25 frequent items with the highest support and support count are
listed. The boldface rows indicate items that contain relationships between 1
or more of the pathogens or TRGs in this study.
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detected with TRGs rose 32% and 24%, respectively. Over
each year, the rate of TRGs co-detected with these five po-
tential pathogens rose a minimum of 3.9%.
Figure 2 displays the time-series co-detection fre-
quency of TRGs with each pathogen segmented by 4
age groups. The patient sample size and total number
of positive tests for each pathogen are included in
Additional file 1: Tables S1-S7. In each age group, the
rates of co-detection between TRGs and each pathogen
increasd with time. Older patients showed a larger co-
detection rate than younger patients. For H. influenzae,
M. catarrhalis, and S. pneumoniae, patients (0–2] had
the lowest rate of co-detection, followed by patients (2–13]
years of age, then patients (50–100] years of age, concluded
by patients (13–50] years of age, which had the highest rate
of co-detection. In 2013, there was an average 33%, 22%,
and 26% difference in co-detection rate from children aged
(0–2] to patients age (13–50] for H. influenzae, M. catar-
rhalis, and S. pneumoniae, respectively. In 2013, an alarm-
ing 82% patients of age (13–50] had TRGs co-detected
with S. pneumoniae. For S. aureus and MRSA, the age
group (13–50] had the highest rate of co-detection between
TRGs and the designated pathogen, but all other age
groups had similar and co-detection frequencies over time.
Figure 3 includes a heatmap indicating the co-detection
frequencies of TRGs and each of the 5 respiratory patho-
gens separated by state from November 2009- August
2013. Additional file 1: Table S9 displays the number of
positive tests recorded from each state and the frequency
that the pathogen was co-detected with a TRG. The high-
est frequency of co-detection occurred in the Northeast,
especially Maryland and New Jersey. In the Southeast,
Florida, Alabama, and Georgia accounted for the largest
percentage of TRG co-detection. Along a westward gradi-
ent, the percentages of TRG co-detection dropped dra-
matically. Louisiana, Oklahoma, Texas, and Colorado all
had co-detection frequencies under 53%. The level of
TRGs co-detected from patients in New Jersey for the five
pathogens was between 54.4% and 86.9%. Moving west-
ward, the frequencies of TRGs co-detected was lower in
Table 2 Association rules
Association rules Support count Support Confidence Lift
{S. pneumoniae}= > {Tetracycline} 9,850 19.76% 54.38% 1.34
{H. influenzae}= > {Tetracycline} 7,543 15.13% 52.82% 1.30
{H. influenzae, S. pneumoniae}= > {Tetracycline} 3,603 7.23% 57.82% 1.43
{S. pneumoniae, M. catarrhalis}= > {Tetracycline} 2,987 5.99% 50.94% 1.26
{Tetracycline, M. catarrhalis}= > {S. pneumoniae} 2,987 5.99% 54.27% 1.49
{H. influenzae, M. catarrhalis}= > {S. pneumoniae} 2,486 4.99% 60.80% 1.67
{K. pneumoniae}= > {Tetracycline} 1,518 3.05% 70.28% 1.73
{H. influenzae, S. pneumoniae, M. catarrahalis}= > {Tetracycline} 1,311 2.63% 52.74% 1.30
{H. influenzae, Tetracycline, M. catarrhalis}= > {S. pneumoniae} 1,311 2.63% 66.68% 1.83
{A.baumannii}= > {Tetracycline} 957 1.92% 53.14% 1.31
{CoxEchovirus1, S.pneumoniae}= > {Tetracycline} 888 1.78% 55.64% 1.37
{CoxEchovirus1, S.pneumoniae}= > {S.pneumoniae} 888 1.78% 55.88% 1.54
{P.aeruginosa}= > {Tetracycline} 812 1.63% 55.43% 1.36
{PVLgene}= > {MRSA} 805 1.62% 93.71% 7.56
{MRSA, S. pneumoniae}= > {Tetracycline} 761 1.53% 61.56% 1.52
{S.pyogenes}= > {Tetracycline} 689 1.38% 71.84% 1.77
{S. aureus, S. pneumoniae}= > {Tetracycline} 651 1.31% 62.59% 1.54
{CoxEchovirus1, H.influenzae}= > {Tetracycline} 646 1.30% 52.48% 1.29
{CoxEchovirus1, H.influenzae}= > {S.pneumoniae} 634 1.27% 51.50% 1.42
{CoxEchovirus1, M.catarrahalis}= > {S.pneumoniae} 627 1.26% 50.64% 1.39
{Rhinovirus, S.pneumoniae}= > {Tetracycline} 594 1.19% 51.65% 1.27
{Rhinovirus, Tetracycline}= > {S.penumoniae} 594 1.19% 53.66% 1.48
{MRSA, M. catarrhalis}= > {Tetracycline} 574 1.15% 55.84% 1.37
{MRSA, H. influenzae}= > {Tetracycline} 556 1.12% 60.30% 1.49
{PVLgene}= > {Tetracycline} 516 1.04% 60.00% 1.48
The first 25 association rules with the highest support and support count are listed. Other calculations include confidence and lift which have measurements over
52.8% and 1.3, respectively for all boldfaced rows.
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Figure 2 The Frequency of TRGs Detected with Respiratory Pathogens Increased in Each Age Group over Time. Each graph displays the
co-detection frequency for each age group and pathogen. The data is aggregated by month. A loess smoothing line passes through data points
and are shaded by 95% confidence intervals.
Figure 1 The frequency of TRGs Detected with Respiratory Pathogens Increased from 2009–2013. The scatterplot shows the rise in
co-detection between TRGs and respiratory pathogens in recent years. The data is aggregated by week. Loess smoothing curves pass through
the data points and are shaded by a 95% confidence interval.
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Tennessee with levels between 42.7% and 55.3% for the
five pathogens. In Texas, the rate of co-detection de-
creased even further to between 33.3% and 10.7%. Since
Eastern states reported a much higher frequency of co-
detection over Western states, a longitudinal trend was
established.
Discussion
Figure 1 indicates that the frequency of co-detection be-
tween the 5 respiratory pathogens and TRGs continues
to rise over time. One trend observed in Figure 1 is the
periodicity, where the co-detection rates of TRGs and
each pathogen reach a maximum during the middle of
each year. The frequency of co-detection is the highest
in the summer and the lowest in the winter of each year.
Various literature report a seasonal incidence of anti-
biotic resistance in various pathogens [31-33]. It is pos-
sible that this trend occurs from fluctuation in the
number of tests physicians administer to patients during
different times of the year. Alternatively, the seasonal
trend here may be occurring because of the different
levels of antibiotics prescribed to patients throughout
the each season, especially during the flu season [33].
The CDC considers the respiratory illness/flu season in
the United States to begin in October and end in May,
peaking in February [34]. As a result of the rise in num-
ber of antibiotics prescribed during February, an in-
creased number of pathogens activate the production of
TRGs [35]. Throughout spring months, TRG up-
regulation and transmission continues to increase until
months after flu season subsides. As a result, the rise in
TRG co-detection frequency seen each summer could be
a delayed effect from the increase in tetracycline expos-
ure from the rise in number of antibiotic prescriptions
that are administered during early winter/spring of each
year. Moreover, these seasonal data could also have a clin-
ical impact as drug therapy could be periodically altered
and antibiotic effectiveness could be increased. Physicians
may have greater success prescribing tetracycline in the
winter when co-detection frequency is lower, than in the
summer when co-detection is at maximum levels. Sea-
sonal trends could be occurring with other first-line anti-
biotics as well, but more studies are needed to test this
hypothesis.
Figure 2 illustrates that all 4 age groups rose in co-
detection frequency over time, but the frequencies of co-
detection follow different trends for the age groups.
Across the 5 pathogens, patients age (0–2] display the
lowest frequency of co-detection of TRGs and respira-
tory pathogens, while patients age (13–50] demonstrate
the highest rate of co-detection. These data suggest that
tetracycline usage can be optimized in different age
groups over the yearly cycle. Even though tetracycline
has the highest chance of being effective in patients age
(0–2], physicians typically avoid prescribing tetracycline
to younger children, as the treatment can cause staining
of permanent teeth [36,37]. Once dental maturity is
reached, the staining of teeth from tetracycline use is no
longer an issue. The avoidance of prescribing tetracyc-
line to infant patients could be an underlying reason for
the lower co-detection measurement in the youngest age
bracket. Alternatively, one approved use of tetracycline
is to combat dermatological pathogens and is a thera-
peutic option for treating young adults with acne
[31,34]. The increased utilization of tetracycline in teen-
age patients could be an underlying cause for the higher
TRG co-detection frequency observed in the (13–50]
age group. In addition, environmental factors such as
diet may have an effect on the large co-detection fre-
quency of both (13–50] and (50–100] age groups. Since
over half the antibiotics produced for use in the United
States are utilized for agricultural purposes, it may be
plausible to hypothesize that the longer a person ingests
tetracycline-infused foods, the greater likelihood that
normal microbial flora build an immunity to the anti-
biotic. Then, when a respiratory pathogen infects a pa-
tient, these flora can pass tetracycline genes to the
foreign pathogen via conjugation [38].
Figure 3 Heatmap Displaying the Longitudinal Effect of TRG Co-detection across the United States. The heat map is ordered by state on
the bottom where the eastern states are on the right and the western states are on the left side of the map. The circles which are most red are
the states that have the highest levels of tetracycline resistance co-detection regarding each pathogen, while states that are the most blue have
the lowest rates. Size of the circles correspond to sample size of the data.
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There are two possible explanations for why a longitu-
dinal effect is observed in Figure 3. Physicians in the
Northeast could be prescribing tetracycline to patients at
higher rates than in other areas of the country. Alterna-
tively, various diets and varieties of food eaten across the
United States could have an impact on different frequen-
cies of TRG and respiratory pathogen co-detection. An
underlying reason for the varying frequencies of TRG
co-detection throughout different regions of the United
States could be because of geographical differences re-
garding tetracycline application in agriculture. The only
outlier in the Western states is Nevada, which has one
of the largest rates of co-detection, but is surrounded by
states that have the lowest levels of co-detection of
TRGs and respiratory pathogens. There is no apparent
hypothesis for why Nevada has a large co-detection fre-
quency. Taken together, these data suggest an environ-
mental influence, but a subsequent analysis of data
estimating per-state tetracycline loads would be needed
to correlate these data to co-detection frequencies.
There are two common causes for increased tetracyc-
line exposure. The first includes excess prescriptions be-
ing provided to patients by physicians and the other
involves overexposure in agriculture and livestock feed.
It is likely that these pathogens contained genes and
pathways that predated the antibiotic era that could
neutralize tetracycline [39,40]. Increased utilization in
the fields of agriculture and medicine allowed these
time-weighted genetic determinants such as synthesis of
inactivation enzymes, efflux pumps, or ribosomal protec-
tion proteins to be up-regulated and passed to other
pathogens via plasmid transfer [39-42]. S. aureus, MRSA,
S. pneumonia, H. influenzae, and M. catarrhalis are all
found in proximity in the upper respiratory tract of most
humans, therefore, it is plausible that these pathogens ex-
change genetic information frequently. The genomes of
many pathogens contain TRGs with the three major genes
including tet (K), tet (M), and tet (O) [1,15,16]. In this
study, only genetic targets for tet (K) and tet (M) were in-
cluded in testing. With the exclusion of tet (O) and other
tet genes, it can be speculated that the actual rate of tetra-
cycline resistance in patients is even higher than seen here.
A strong hypothesis for the high frequencies of TRG
co-detection is that the high tetracycline use in agricul-
ture facilitates tetracycline resistant gene activations,
which is then passed to other pathogens via conjugation.
The rampant use of antibiotics is a more pressing issue
in the United States than in other countries because over
half the antibiotics that are produced in the United
States are used for agricultural purposes, an extremely
high percentage [3,4]. For many years it has been disputed
whether or not antibiotic use in agriculture is responsible
for the rise in the number of antibiotic resistant patho-
gens. The FDA argues antibiotic levels recommended for
agricultural use have been tested in a laboratory setting
on bacteria in culture, with very low frequencies of
pathogens acquiring resistance [43]. However, some
literature demonstrates that sub-inhibitory antibiotic
exposure can cause development of resistance over time
[44-47]. Recently, the FDA has begun to regulate the
amount of antibiotics utilized in the agricultural and
medical industries [9]. Playing close attention to the
levels of pathogens that are becoming resistant to anti-
biotics is imperative because throughout the past
15 years only 9 new antibiotics have been approved to
combat certain illnesses [8]. Since there are a limited
number of new antibiotic medications in the develop-
mental pipeline, it is important to monitor levels of
tetracycline resistant pathogens so that the medication
can continue to be an effective treatment for acne and
uncomplicated community-acquired MRSA [48-50].
Conclusion
After a data mining analysis, it is clear that there is a
relationship between S. aureus, MRSA, S. pneumoniae,
H. influenzae, and M.catarrhalis and the co-detection of
TRGs. Since 2010, there has been a rise in TRG co-
detection by at least 24% for each of the five potential re-
spiratory pathogens studied and co-detection frequency is
more widespread in summer months than in winter
months. Patients aged (13–50] show the highest rate of
TRG co-detection with respiratory pathogens, while pa-
tients aged (0–2] show the lowest frequency. These find-
ings could correlate with the deleterious effect of
tetracycline prescriptions given to younger children be-
cause of medication side-effects or the large amount of
teenagers who are prescribed tetracycline for the effective
treatment of acne. Partitioned by geography, the North-
eastern United States demonstrated the largest percentage
of TRG co-detection, while co-detection rates decreased
longitudinally westward.
The CDC has realized that antibiotic resistance is the
largest threat to future global health and these data further
underscore the need for careful management of antibi-
otics. By establishing certain trends regarding tetracycline
resistance, we can begin to uncover underlying causes for
the rise in TRG co-detection frequency. These data are
consistent with the hypothesis that environmental pres-
sures in medicine and agriculture effect levels of TRGs. As
a result, many people who have been educated on the
overuse of antibiotics in society have switched to strict or-
ganic diets so that the risk of coming in contact with
TRGs is minimized. Moreover, the FDA, CDC, and De-
partment of Agriculture are beginning to revise regula-
tions regarding antibiotic usage. The overuse of antibiotics
in society is an ongoing controversial topic. However, the
continuous monitoring of co-detection rates between
pathogens and antibiotic resistance genes is imperative so
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that physicians can assess the effectiveness of an antibiotic
at the time of infection and provide optimal patient care.
Further studies are needed to generalize these descrip-
tive findings to a larger population and to associate envir-
onmental factors with the rise in tetracycline resistance.
We hope that this study fosters a rich discussion of this vi-
tally important medical topic.
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